LON:CSRT Consort Medical plc (CSRT.L) (CSRT) Share Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About Consort Medical plc (CSRT.L) Stock (LON:CSRT) 30 days 90 days 365 days Advanced Chart Ad Chaikin Analytics320 hedge funds just sold this stock320 hedge funds just sold this stock A strange force has seized control of Wall Street. Hedge funds are already moving their money… and preparing for even stranger days ahead. Over 320 hedge funds have quietly sold THIS famous stock – to prepare for a dramatic market shiftGet the strange truth from a 50-year Wall Street insider… including the name and ticker of the stock Get CSRT alerts:Sign Up Key Stats Today's Range N/A50-Day Range 1,010▼ 1,01052-Week Range N/AVolume768 shsAverage Volume520,697 shsMarket Capitalization£504.60 millionP/E Ratio127.85Dividend Yield2.75%Price TargetN/AConsensus RatingN/A Company OverviewConsort Medical plc operates as a one-stop developer and manufacturer of drugs and premium drug delivery devices. It operates through two divisions, Bespak and Aesica. The company provides various life improving treatments to patients across worldwide through the design, development, and manufacture of medical devices for inhaled, injectable, nasal, and ocular drug delivery, as well as point of care diagnostics products. It also develops, formulates, and manufactures active pharmaceutical ingredients and finished dose drugs. Consort Medical plc was incorporated in 1946 and is headquartered in Hemel Hempstead, the United Kingdom.Read More… 320 hedge funds just sold this stock (Ad)320 hedge funds just sold this stock A strange force has seized control of Wall Street. Hedge funds are already moving their money… and preparing for even stranger days ahead. Over 320 hedge funds have quietly sold THIS famous stock – to prepare for a dramatic market shiftGet the strange truth from a 50-year Wall Street insider… including the name and ticker of the stock Receive CSRT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Consort Medical plc (CSRT.L) and its competitors with MarketBeat's FREE daily newsletter. Email Address CSRT Stock News HeadlinesConsort Medical plc (CSRT.L) (LON:CSRT) Shares Cross Above Two Hundred Day Moving Average of $1,010.00September 26, 2024 | americanbankingnews.comMD Medical Group Investments PLC DRMay 11, 2024 | morningstar.com$20 = Ounce of Gold?I've discovered a way to get exposure to MORE than an ounce of gold... for under $20. It's not bullion. It's not ETFs. And it's certainly not crypto.October 2, 2024 | Monument Traders Alliance (Ad)Medical Guardian Mini Guardian ReviewApril 11, 2024 | forbes.comFAMDF Futura Medical plcDecember 15, 2023 | seekingalpha.comL.A. County wants to buy — and forgive — your medical debt. Here’s how that would workOctober 6, 2023 | latimes.comKETL.L - Strix Group PlcJuly 11, 2023 | finance.yahoo.comSAFE.L - Safestore Holdings plcJune 14, 2023 | finance.yahoo.comSee More Headlines CSRT Stock Analysis - Frequently Asked Questions How do I buy shares of Consort Medical plc (CSRT.L)? Shares of CSRT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What other stocks do shareholders of Consort Medical plc (CSRT.L) own? Based on aggregate information from My MarketBeat watchlists, some other companies that Consort Medical plc (CSRT.L) investors own include Chubb (CB), Newcrest Mining (NCM), Petrel Resources (PET), Barrick Gold (ABX), Atco Mining (ATMGF), Bank of Ireland Group (BKRIY) and Caleres (CAL). Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Medical Appliances & Equipment Sub-IndustryN/A Current SymbolLON:CSRT CUSIPN/A CIKN/A Webwww.consortmedical.com Phone+44-1442-867920FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio127.85 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio55.58 Current Ratio1.83 Quick Ratio1.16 Sales & Book Value Annual Sales£298.60 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow33.44 Book ValueGBX 465.50 per share Price / BookN/AMiscellaneous Outstanding Shares49,960,600Free FloatN/AMarket Cap£504.60 million OptionableNot Optionable BetaN/A 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report This page (LON:CSRT) was last updated on 10/2/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored320 hedge funds just sold this stock320 hedge funds just sold this stock A strange force has seized control of Wall Street. Hedge funds are alr...Chaikin Analytics | SponsoredThey laughed when he picked Nvidia in 2016…Everyone’s talking about AI right now, but I’ve been talking about it for years. And now I’ve just released...Brownstone Research | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredFor Elon, I fear the worst is yet to come…Early last year I predicted that there would be a war on Elon Musk. This hateful rhetoric has led to two s...Porter & Company | SponsoredWho are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Consort Medical plc (CSRT.L) Please log in to your account or sign up in order to add this asset to your watchlist. Share Consort Medical plc (CSRT.L) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.